Molecular imaging in oncology

Egesta Lopci, Stefano Fanti

Research output: Chapter in Book/Report/Conference proceedingChapter


The major application for PET imaging in clinical practice is represented by cancer imaging and 18F-FDG is the most widely employed positron emitter compound. However, some diseases cannot be properly evaluated with this tracer and thus there is the necessity to develop more specific compounds. The last decades were a continuous factory for new radiopharmaceuticals leading to an endless list of PET tracers; however, just some of them guard diagnostic relevance in routine medical practice. This chapter describes a selected list of non-FDG PET tracers, basing on their introduction into and impact on clinical practice.

Original languageEnglish
Title of host publicationRecent Results in Cancer Research
Number of pages30
Publication statusPublished - 2013

Publication series

NameRecent Results in Cancer Research
ISSN (Print)00800015

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Molecular imaging in oncology'. Together they form a unique fingerprint.

Cite this